Invention Grant
- Patent Title: Griseofulvin compound and pharmaceutical use thereof
-
Application No.: US16648570Application Date: 2018-09-28
-
Publication No.: US11407746B2Publication Date: 2022-08-09
- Inventor: Keiji Saito , Katsuyoshi Nakajima , Yasuyuki Ogawa , Mitsuhiro Makino , Kaori Ito , Seiko Nagata , Makoto Hirasawa
- Applicant: Daiichi Sankyo Company, Limited
- Applicant Address: JP Tokyo
- Assignee: Daiichi Sankyo Company, Limited
- Current Assignee: Daiichi Sankyo Company, Limited
- Current Assignee Address: JP Tokyo
- Agency: Myers Bigel, P.A.
- Priority: JPJP2017-191690 20170929
- International Application: PCT/JP2018/036160 WO 20180928
- International Announcement: WO2019/065928 WO 20190404
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D307/94 ; C07D405/10 ; C07D413/10 ; C07D309/12 ; C07D407/12 ; C07D405/14 ; C07D498/10
Abstract:
The present invention addresses the problem of providing a compound for prophylaxis and/or treatment of central inflammatory diseases, or a pharmacologically acceptable salt thereof. The present invention addresses a compound of a general formula (I) or a pharmacologically acceptable salt thereof as a means to solve the problem. [R1: a C1-C6 alkyl group or the like, R2: a C1-C6 alkyl group or the like, A: a 5-membered aromatic hetero-ring or the like, R3, R3′: a C1-C6 alkyl group or the like.
Public/Granted literature
- US20200216433A1 GRISEOFULVIN COMPOUND AND PHARMACEUTICAL USE THEREOF Public/Granted day:2020-07-09
Information query
